Fortune® has named Prestige Brands Holdings, Inc. (NYSE-PBH) as one of its 100 fastest growing companies. Listed as #60, PBH markets and distributes brand name over-the-counter healthcare products throughout the U.S., Canada, and in certain international markets.
The Fortune list measures companies by growth in revenue, profit and stock price over the past three years. Prestige’s strong financial performance included a 30% revenue growth, 30% adjusted EPS growth and 60% total return for the three-year period.
“Our strategy for creating shareholder value has three prongs which work in tandem: invest in and grow our core over-the-counter healthcare brands, harness our financial profile and industry-leading free cash flow to pay down debt and build M&A capacity, and remain aggressive and disciplined in the M&A market,” said Matthew M. Mannelly, CEO. “The successful execution of this strategy worked to create the results for which we are recognized on this important Fortune list,” he said.
Prestige Brands is the largest independent publicly-traded OTC products company in America. The company’s core brands include Chloraseptic
® sore throat treatments, Clear Eyes
® eye care products, Compound W
® wart treatments, Little Remedies
® and PediaCare
® pediatric over-the-counter healthcare products, The Doctor’s
® NightGuard® dental protector, Efferdent
® denture care products, Luden’s
® throat drops, Dramamine
® motion sickness treatment, BC
® and Goody’s
® headache remedies, Beano
® gas prevention, Debrox
® earwax remover, and in Canada, Gaviscon
® antacid. (Fortune is a registered trademark of Time Inc.)